Last reviewed · How we verify
NCT05249192
Immediate Versus Early (24-hours) Urinary Catheter Removal After Elective Minimally Invasive Colonic Resection
NA trial testing Immediate urinary catheter removal in Surgical Complication in 216 participants. Completed in 26 November 2024.
1 July 2024
Quick facts
| Lead sponsor | Azienda Ospedaliera Universitaria Integrata Verona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 216 |
| Start date | 15 February 2022 |
| Primary completion | 1 July 2024 |
| Estimated completion | 26 November 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Immediate urinary catheter removal
- Early urinary catheter removal
Conditions studied
- Surgical Complication — all drugs for Surgical Complication →
- Colonic Disease — all drugs for Colonic Disease →
- Postoperative Complications — all drugs for Postoperative Complications →
- Urinary Retention Postoperative — all drugs for Urinary Retention Postoperative →
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona — full company profile →
Who can join
Adults 18 to 80, any sex, with Surgical Complication or Colonic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of this study is to compare the rate of acute urinary retention (AUR) after immediate compared to early (24-hours) removal of urinary catheter (UC) in patients undergoing minimally invasive colorectal resection. The study hypothesis is that immediate UC removal is non-inferior to 24-hours UC removal in terms of AUR rate. The secondary outcomes focus on goals that could be positively impacted by the immediate removal of the UC at the end of the surgery. In particular, the rate of urinary tract infections, perception of pain, time-to-return of bowel and physical functions, postoperative complications and postoperative length of stay will all be measured.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Immediate versus early (24-hours) urinary catheter removal after elective minimally invasive colonic resection: study protocol for a randomized, multicenter, non-inferiority trial.
Pedrazzani C, Montroni I, Conti C, Turri G, et al · · 2022 · cited 3× · PMID 36414969 · DOI 10.1186/s13063-022-06894-6 -
Immediate versus early (24-hours) urinary catheter removal after elective minimally invasive colonic resection: study protocol for a randomized, multicenter, non-inferiority trial
Pedrazzani C, Montroni I, Conti C, Turri G, et al · · 2022 · DOI 10.21203/rs.3.rs-1385347/v1
Verify or expand the search:
- PubMed search for NCT05249192
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Immediate urinary catheter removal
Trials testing the same drug.
- NCT06769087 — Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery · NA · enrolling by invitation
Other recruiting trials for Surgical Complication
Currently open trials in the same condition.
- NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
- NCT06649890 — A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™ · NA · recruiting
- NCT07059104 — Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study · recruiting
- NCT06270407 — The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery · Phase 4 · recruiting
- NCT06315582 — Surgical Approach to Uterine Septum · NA · recruiting
Other Azienda Ospedaliera Universitaria Integrata Verona trials
Trials by the same sponsor.
- NCT07325877 — Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis · NA · not yet recruiting
- NCT07289035 — Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. · Phase 2 · not yet recruiting
- NCT07186582 — Verona Coronary Physiology Interventional Registry · active not recruiting
- NCT06820541 — Gallbladder Stenting in FC-SEMS · NA · not yet recruiting
- NCT07338708 — Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05249192 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Universitaria Integrata Verona
- Last refreshed: 29 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05249192.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing